Glenn Coleman

Insider profile

Currently holds positions in Integra Lifesciences Holdings Corp and Derma Sciences Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Operating Officer, Executive Vice President Integra Lifesciences Holdings Corp June 24, 2019 -
Vice President, Treasurer, Assistant Secretary, Director Derma Sciences Inc Feb. 24, 2017 -
Chief Financial Officer, Corporate Vice President International Integra Lifesciences Holdings Corp Oct. 17, 2017 - June 24, 2019
Chief Financial Officer, Principal Accounting Officer, Corporate Vice President Integra Lifesciences Holdings Corp May 2, 2014 - Oct. 17, 2017
Vice President, Corporate Controller Curtiss-Wright Corporation May 6, 2008 - May 1, 2014
Glenn Coleman's trades of Charles River Laboratories International, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
479.30
Quantity 82,004
Value US$3,328,887
Transaction date
Purchase
Price
438.39
Quantity 13,662 -8.5%
Value US$1,515,557
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-09-30
PP Planned purchase
71,942 +24.7%
118.18
US$2,873,927 		71,942 +24.7% 118.18 US$2,873,927
2025-01-27 2025-01-27
PrS Proposed sale
82,004
479.30
US$3,328,887 		82,004 479.30 US$3,328,887
2023-11-20 2023-11-20
B Purchase
13,662 -8.5%
438.39
US$1,515,557 		13,662 -8.5% 438.39 US$1,515,557
2022-04-06 2022-04-04
PlS Planned sale
6,268 -13.2%
66.04
US$413,939 		6,268 -13.2% 66.04 US$413,939
2021-11-03 2021-11-02
PlS Planned sale
4,275 -13.3%
74.00
US$316,350 		4,275 -13.3% 74.00 US$316,350
2021-04-19 2021-04-16
PlS Planned sale
25,658 -44.5%
71.50
US$1,834,547 		25,658 -44.5% 71.50 US$1,834,547
2021-04-15 2021-04-14
PlS Planned sale
4,002 -11.1%
70.50
US$282,141 		4,002 -11.1% 70.50 US$282,141
2021-04-12 2021-04-09
PlS Planned sale
12,500 -25.7%
70.00
US$875,000 		12,500 -25.7% 70.00 US$875,000
2021-03-30 2021-03-29
PlS Planned sale
12,500 -25.7%
68.50
US$856,250 		12,500 -25.7% 68.50 US$856,250
2021-03-30 2021-03-29
PlS Planned sale
3,000 -7.7%
68.50
US$205,500 		3,000 -7.7% 68.50 US$205,500
2020-11-17 2020-11-13
PlS Planned sale
2,600 -7.1%
56.03
US$145,666 		2,600 -7.1% 56.03 US$145,666
2020-11-12 2020-11-09
PlS Planned sale
4,400 -10.8%
56.04
US$246,597 		4,400 -10.8% 56.04 US$246,597
2020-11-12 2020-11-09
PlS Planned sale
93 -0.2%
55.04
US$5,119 		93 -0.2% 55.04 US$5,119
2020-11-12 2020-11-09
PlS Planned sale
4,907 -10.7%
54.34
US$266,668 		4,907 -10.7% 54.34 US$266,668
2020-08-13 2020-08-11
PlS Planned sale
5,000 -9.8%
52.27
US$261,342 		5,000 -9.8% 52.27 US$261,342
2019-07-26 2019-07-24
PlS Planned sale
3,500 -9.0%
57.50
US$201,250 		3,500 -9.0% 57.50 US$201,250
2019-07-02 2019-06-28
PlS Planned sale
3,650 -12.7%
55.00
US$200,750 		3,650 -12.7% 55.00 US$200,750